Telbid MT 40mg/50mg Tablet ER

Name: Telbid MT 40mg/50mg Tablet ER
Brand: Eswar Therapeutics Pvt Ltd
Price: 130 INR

Prescription Required

Marketer

Eswar Therapeutics Pvt Ltd

Salt Composition

Telmisartan (40mg) + Metoprolol Succinate (50mg)

Overview Telbid MT 40mg/50mg Tablet ER

CardioAce 40mg/50mg Extended-Release Tablets manage hypertension, reducing the risk of strokes and heart attacks. Early use improves heart attack survival rates. For consistent blood levels, take CardioAce with food daily, as prescribed. Continue treatment as directed; don't stop even if feeling well, as hypertension is often asymptomatic. Lifestyle changes, including exercise, weight management, and healthy eating, further enhance blood pressure control. Follow your physician's instructions closely. Potential side effects include headache, weakness, dizziness, low blood pressure, elevated potassium, occasional orthostatic hypotension (possibly with fainting), shortness of breath, nausea, vomiting, stomach pain, and tiredness. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and rise slowly. Regular monitoring of blood pressure, blood sugar, kidney function, urea, and electrolytes may be necessary. Inform your doctor of any liver or kidney issues before starting. Pregnant or breastfeeding individuals should seek medical advice before use. Disclose all current medications, particularly those for hypertension or heart conditions.

Uses of Telbid MT 40mg/50mg Tablet ER

Managing elevated blood pressure

Major Benefits of Telbid MT 40mg/50mg Tablet ER:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Telbid MT 40mg/50mg Extended-Release Tablet with a meal.

Common Side effects of Telbid MT 40mg/50mg Tablet ER:

Headache
Weakness
Dizziness
Cold extremities
Slow heart rate
Increased potassium level in blood
Decreased blood pressure
Orthostatic hypotension (sudden lowering of blood pressure on standing)
Breathlessness
Vomiting
Abdominal pain

How to use Telbid MT 40mg/50mg Tablet ER:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the entire tablet without chewing, crushing, or breaking it. Consume Telbid MT 40mg/50mg Extended-Release tablets with food.

How Telbid MT 40mg/50mg Tablet ER works:

Extended-release Telbid MT tablets (40mg/50mg) contain Telmisartan and Metoprolol Succinate, a dual-action formulation for hypertension management.

SAFETY ADVICE

AlcoholUNSAFE

Combining Telbid MT 40mg/50mg Extended-Release Tablets with alcohol is unsafe.

PregnancyCONSULT YOUR DOCTOR

Extended-release Telbid MT 40mg/50mg tablets pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional circumstances involving a life-threatening condition, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingSAFE IF PRESCRIBED

Extended-release Telbid MT 40mg/50mg tablets are likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.

DrivingUNSAFE

Extended-release Telbid MT 40mg/50mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if experiencing these effects.

KidneySAFE IF PRESCRIBED

For individuals with kidney impairment, Telbid MT 40mg/50mg Extended-Release tablets are considered safe. No dosage modification is advised for Telbid MT 40mg/50mg Extended-Release tablets in this patient population.

LiverCAUTION

Patients with hepatic impairment should use Telbid MT 40mg/50mg Extended-Release Tablets cautiously, potentially requiring dosage modification. Physician consultation is recommended.

What if you forget to take Telbid MT 40mg/50mg Tablet ER :

Should you forget a Telbid MT 40mg/50mg Extended-Release Tablet, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication timetable. Avoid taking a double dose.

Facts to Know About Telbid MT 40mg/50mg Tablet ER

Label	Value
Developing Habits	No.
Treatment Category	Heart

FAQs on Telbid MT 40mg/50mg Tablet ER

Telbid MT 40mg/50mg Tablet ER Succinate may cause dizziness, especially when standing up suddenly from a lying or sitting position. To minimize this risk, rise slowly from a seated or reclined position.

Telbid MT 40mg/50mg Tablet ER Succinate works best when combined with healthy lifestyle choices. Quitting smoking significantly reduces your risk of heart attack and stroke. Weight management, through diet and exercise, is also crucial. A balanced diet rich in fruits and vegetables, along with regular physical activity, strengthens the heart and lowers heart attack risk.

Continue taking your prescribed Telbid MT 40mg/50mg Tablet ER, even if you feel healthy. Abruptly stopping this medication can cause severe health problems, including heart attack and stroke.

Store this medication in its original, tightly closed container, following the storage instructions on the packaging. Discard any unused medication. Keep it out of reach of children, pets, and others.

MRP 150

13% off

130

Inclusive of all taxes

Quantity:

of Tablet ER

Telbid MT 40mg/50mg Table...

130